Skip to main content
SpringerLink
Log in

TUG1 as a Therapy Target in Pancreatic Cancer

  • Correspondence
  • Published:
Digestive Diseases and Sciences Aims and scope Submit manuscript

This is a preview of subscription content, log in via an institution to check access.

Access this article

Log in via an institution

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Institutional subscriptions

References

  1. Xu K, Zhang L. Inhibition of TUG1/miRNA-299-3p axis represses pancreatic cancer malignant progression via suppression of the notch1 pathway. Dig Dis Sci. 2020;65:1748–1760. https://doi.org/10.1007/s10620-019-05911-0.

    Article  CAS  PubMed  Google Scholar 

  2. Li Y, Zheng D, Pan L, et al. Knockdown of TUG1 by shRNA inhibited renal cell carcinoma formation by miR-299-3p/VEGF axis in vitro and in vivo. Eur J Pharmacol. 2019;860:172536.

    CAS  PubMed  Google Scholar 

  3. Ma F, Wang SH, Cai Q, et al. Long non-coding RNA TUG1 promotes cell proliferation and metastasis by negatively regulating miR-300 in gallbladder carcinoma. Biomed Pharmacother. 2017;88:863–869.

    CAS  PubMed  Google Scholar 

  4. Fang Q, Liu T, Yu C, et al. LncRNA TUG1 alleviates cardiac hypertrophy by targeting miR-34a/DKK1/Wnt-β-catenin signalling. J Cell Mol Med. 2020;24:3678–3691.

    CAS  PubMed  PubMed Central  Google Scholar 

  5. Xu Y, Deng W, Zhang W. Long non-coding RNA TUG1 protects renal tubular epithelial cells against injury induced by lipopolysaccharide via regulating microRNA-223. Biomed Pharmacother. 2018;104:509–519.

    CAS  PubMed  Google Scholar 

Download references

Author information

Authors and Affiliations

  1. Department of Surgery, Liaocheng Cancer Hospital, Liaocheng, 252000, People’s Republic of China

    Haifeng Liang

  2. Department of Anesthesia and Surgery Center, Liaocheng Cancer Hospital, Liaocheng, 252000, People’s Republic of China

    Zhaokun Cui

  3. Department of Thoracic Surgery, Liaocheng Cancer Hospital, Liaocheng, 252000, People’s Republic of China

    Qingping Song

Authors
  1. Haifeng Liang
    View author publications

    You can also search for this author in PubMed Google Scholar

  2. Zhaokun Cui
    View author publications

    You can also search for this author in PubMed Google Scholar

  3. Qingping Song
    View author publications

    You can also search for this author in PubMed Google Scholar

Corresponding author

Correspondence to Qingping Song.

Ethics declarations

Conflict of Interest

The authors declare that they have no conflicts of interest.

Additional information

Publisher’s Note

Springer Nature remains neutral with regard to jurisdictional claims in published maps and institutional affiliations.

Rights and permissions

Reprints and permissions

About this article

Check for updates. Verify currency and authenticity via CrossMark

Cite this article

Liang, H., Cui, Z. & Song, Q. TUG1 as a Therapy Target in Pancreatic Cancer. Dig Dis Sci 65, 3756–3757 (2020). https://doi.org/10.1007/s10620-020-06636-1

Download citation

  • Received:

  • Accepted:

  • Published:

  • Issue Date:

  • DOI: https://doi.org/10.1007/s10620-020-06636-1

Search

Navigation